RECURSION PHARMACEUTICALS IN

Q2 2026 13F Holders

CUSIP
75629V954
Type
Equity
Class
PUT
Num filings
5
Total reported value, excl. options
$592 k
Manager Report Date Value ($000) Shares Option Type